The cAMP pathway has key physiological effects on heart function and is essential for the chronotropic, inotropic and lusitropic effects during the 'fight-or-flight'response. However, chronic activation of the cAMP pathway induces hypertrophic growth and ventricular dysfunction, which ultimately leads to the development of chamber dilatation and heart failure. Despite the description of a number of alterations in the cAMP pathway during hypertrophy and heart failure, the exact mechanisms accounting for the cardiotoxicity of this pathway are not fully understood. Much research has been dedicated to understanding the roles in heart for types 5 and 6 adenylyl cyclase (AC), the enzymes that synthesize cAMP. However roles for additional ACs expressed in cardiac myocytes have been largely overlooked. We have recently shown that type 9 AC is not only expressed in adult mouse cardiomyocytes, but is the only AC isoform to associate with the Yotiao- IKs complex in both transgenic mouse models and guinea pig heart. Sympathetic responses increase cAMP signaling which increases IKs current and shortening of the action potential duration to allow sufficient diastolic intervals in the face of increased heart rate. Mutations that disrupt interactons between the IKs channel subunit (KCNQ1) and the scaffolding protein Yotiao give rise to Long-QT syndrome. We have provided significant evidence that adenylyl cyclase (AC) is an integral part of signaling scaffolds known as A-kinase anchoring proteins (AKAPs) that coordinate events both upstream and downstream of cAMP production. We hypothesize that AC9 plays a key role in cAMP regulation of cardiac function and IKs regulation via interactions with Yotiao and possibly additional AKAPs.
Specific Aims will 1) examine the enzymatic regulation of AC9 and real-time production of cAMP in cardiac myocytes, 2) identify and characterize AC9 complexes in cardiac myocytes, and 3) examine the functional roles of AC9 in heart.

Public Health Relevance

Lay summary Long-QT syndrome is defined by fast or irregular heart rhythms. These can trigger fainting, seizures, or even sudden death. Genetic mutations in KCNQ1 or its anchoring protein Yotiao, give rise to ~35% of all patients with Long-QT. We have identified type 9 adenylyl cyclase (AC9) as a component of a macromolecular complex containing KCNQ1-Yotiao that regulates cardiac repolarization. A better understanding of mechanisms that regulate AC9 and its interactions with Yotiao, KCNQ1, and other scaffolding proteins will uncover new strategies for therapeutic interventions of Long-QT and possibly additional heart diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM060419-15
Application #
8737274
Study Section
Molecular and Integrative Signal Transduction Study Section (MIST)
Program Officer
Dunsmore, Sarah
Project Start
1999-12-01
Project End
2017-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
15
Fiscal Year
2014
Total Cost
$397,679
Indirect Cost
$108,221
Name
University of Texas Health Science Center Houston
Department
Biology
Type
Schools of Medicine
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
Navarro, Gemma; Cordomí, Arnau; Casadó-Anguera, Verónica et al. (2018) Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase. Nat Commun 9:1242
Ferré, Sergi; Bonaventura, Jordi; Zhu, Wendy et al. (2018) Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A2A-Dopamine D2 Receptor Heterotetramers and Adenylyl Cyclase. Front Pharmacol 9:243
Baldwin, Tanya A; Dessauer, Carmen W (2018) Function of Adenylyl Cyclase in Heart: the AKAP Connection. J Cardiovasc Dev Dis 5:
Dessauer, Carmen W; Watts, Val J; Ostrom, Rennolds S et al. (2017) International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases. Pharmacol Rev 69:93-139
Li, Yong; Baldwin, Tanya A; Wang, Yan et al. (2017) Loss of type 9 adenylyl cyclase triggers reduced phosphorylation of Hsp20 and diastolic dysfunction. Sci Rep 7:5522
Dessauer, Carmen W (2017) Shining a light on GPCR complexes. J Biol Chem 292:14290-14291
Brust, Tarsis F; Alongkronrusmee, Doungkamol; Soto-Velasquez, Monica et al. (2017) Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties. Sci Signal 10:
Bavencoffe, Alexis; Li, Yong; Wu, Zizhen et al. (2016) Persistent Electrical Activity in Primary Nociceptors after Spinal Cord Injury Is Maintained by Scaffolded Adenylyl Cyclase and Protein Kinase A and Is Associated with Altered Adenylyl Cyclase Regulation. J Neurosci 36:1660-8
Brand, Cameron S; Sadana, Rachna; Malik, Sundeep et al. (2015) Adenylyl Cyclase 5 Regulation by G?? Involves Isoform-Specific Use of Multiple Interaction Sites. Mol Pharmacol 88:758-67
Yakubovich, Daniel; Berlin, Shai; Kahanovitch, Uri et al. (2015) A Quantitative Model of the GIRK1/2 Channel Reveals That Its Basal and Evoked Activities Are Controlled by Unequal Stoichiometry of G? and G??. PLoS Comput Biol 11:e1004598

Showing the most recent 10 out of 47 publications